胰十二指肠切除术后高淀粉酶血症的预后因素分析
该研究前瞻性纳入359例胰十二指肠切除术患者,以术后0~1天血清淀粉酶大于120 U/L定义高淀粉酶血症,238例(66.3%)发生。多因素分析显示主胰管直径≤3 mm、胰腺质软及病理类型为胰腺癌或胰腺炎是高淀粉酶血症的独立预后因素,且高淀粉酶血症组临床相关胰瘘、中重度出血、腹腔感染发生率及并发症严重程度和术后住院时间均更高。
要点
- 胰十二指肠切除术后高淀粉酶血症发生率为66.3%(238/359)。
- 主胰管直径≤3 mm、胰腺质软、病理类型为胰腺癌或胰腺炎是高淀粉酶血症独立预后因素。
- 高淀粉酶血症组临床相关胰瘘、中重度出血、腹腔感染及CD分级≥Ⅲ级并发症比例更高。
核心结论
- 胰十二指肠切除术后高淀粉酶血症增加术后并发症的发生率和严重程度。
- 主胰管直径≤3 mm、胰腺质软及病理类型为胰腺癌或胰腺炎是高淀粉酶血症的独立预后因素。
研究设计与样本
- 前瞻性收集2017年1月至2018年6月海军军医大学长海医院同一团队完成的359例胰十二指肠切除术患者临床资料。
- 男性212例,女性147例,中位年龄63岁(范围:23~82岁)。
- 以术后0~1天血清淀粉酶120 U/L为界分为高淀粉酶血症组和非高淀粉酶血症组,采用单因素分析和Logistic回归多因素分析。
主要发现
- 359例中术后发生高淀粉酶血症238例(66.3%)。
- 高淀粉酶血症组临床相关胰瘘发生率15.1%比2.5%(P<0.01),中重度出血8.8%比2.5%(P<0.01),腹腔感染9.2%比3.3%(P=0.04)。
- 高淀粉酶血症组CD分级≥Ⅲ级并发症发生率11.3%比4.1%(P=0.023),术后住院时间11天比9天(P=0.001)。
关键数值与推荐
- 主胰管直径≤3 mm的OR=4.469,95%CI:2.563~7.793,P<0.01。
- 病理类型为胰腺癌或胰腺炎的OR=0.230,95%CI:0.122~0.436,P<0.01。
- 胰腺质软的OR=3.297,95%CI:1.930~5.635,P<0.01。
临床怎么用
- 术后0~1天血清淀粉酶大于120 U/L提示高淀粉酶血症,应警惕临床相关胰瘘、出血和腹腔感染风险。
- 对主胰管直径≤3 mm、胰腺质软或病理为胰腺癌/胰腺炎的患者,术后可加强监测与并发症防范。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the prognostic factors of hyperamylasemia following pancreaticoduodenectomy (PD) . Methods: Clinical data of 359 patients were collected prospectively who underwent PD by the same group at Changhai Hospital of Navy Medical University from January 2017 to June 2018.There were 212 males and 147 females.The median age was 63 years old (range: 23 to 82 years old) .According to whether the patient's serum amylase was greater than 120 U/L at 0 or 1 day after surgery,the patients were divided into hyperamylasemia group and non-hyperamylasemia group. Univariate analysis and multivariate analysis were used to find out the prognostic factors of hyperamylasemia after PD. Results: Of the 359 patients, 238 cases (66.3%) developed hyperamylasemia.The incidence rate of clinically related pancreatic fistula (15.1% vs.2.5%, P<0.01) , grade B/C post pancreatectomy hemorrhage (8.8% vs. 2.5%, P<0.01) , and surgical site infection (9.2% vs. 3.3%, P=0.04) was significantly higher in the hyperamylasemia group.The severity of complications (CD grade≥Ⅲ: 11.3% vs.4.1%, P=0.023) and postoperative hospital stay (11 days vs. 9 days, P=0.001) were higher in the hyperamylasemia group.In the multivariate analysis, the main pancreatic duct diameter (MPD) ≤3 mm (OR=4.469, 95% CI: 2.563-7.793, P<0.01) , pathological type of disease (pancreatic cancer or pancreatitis) (OR=0.230, 95% CI: 0.122-0.436, P<0.01) and soft texture of pancreas (OR=3.297, 95%CI: 1.930-5.635, P<0.01) were independent prognostic factors for hyperamylasemia. Conclusions: Post-PD hyperamylasemia increased the incidence and severity of postoperative complications after PD.MPD≤3 mm, soft texture of pancreas and pathological type of disease were independent prognostic factors of hyperamylasemia. 目的: 探讨胰十二指肠切除术后发生高淀粉酶血症的预后因素。 方法: 前瞻性收集2017年1月至2018年6月海军军医大学长海医院同一团队完成的359例胰十二指肠切除术患者的临床资料。男性212例,女性147例,中位年龄63岁(范围:23~82岁)。以术后0~1 d血清淀粉酶120 U/L为界,将患者分为高淀粉酶血症组和非高淀粉酶血症组。采用单因素分析、Logistic回归多因素分析的方法,分析胰十二指肠切除术后发生高淀粉酶血症的预后因素。 结果: 359例患者中,术后发生高淀粉酶血症238例(66.3%)。高淀粉酶血症组患者的临床相关胰瘘(CR-POPF)(15.1%比2.5%;χ(2)=13.249,P<0.01)、中重度出血(8.8%比2.5%;χ(2)=5.176,P<0.01)、腹腔感染(9.2%比3.3%;χ(2)=4.210,P=0.04)发生率明显高于非高淀粉酶血症组。高淀粉酶血症组患者并发症严重程度(CD分级≥Ⅲ级:11.3%比4.1%;χ(2)=5.139,P=0.023)和术后住院时间(11 d比9 d,P=0.001)亦高于非高淀粉酶血症组。对高淀粉酶血症的多因素分析结果显示,主胰管直径≤3 mm(OR=4.469,95%CI:2.563~7.793,P<0.01)、病理学类型为胰腺癌或胰腺炎(OR=0.230,95%CI:0.122~0.436,P<0.01)及胰腺质软(OR=3.297,95%CI:1.930~5.635,P<0.01)是高淀粉酶血症的独立预后因素。 结论: 胰十二指肠切除术后高淀粉酶血症增加了患者术后并发症的发生率和严重程度,主胰管较细、胰腺质软及病理学类型为胰腺癌或胰腺炎是胰十二指肠切除术后高淀粉酶血症的独立预后因素。.
引用
- Wang H, Shao Z, Guo SW, et al. [Analysis of prognostic factors for hyperamylasemia following pancreaticoduodenectomy]. Zhonghua Wai Ke Za Zhi. 2019. PMID: 31269617. doi:10.3760/cma.j.issn.0529-5815.2019.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。